BioSpace News Archive

MAIA Biotechnology, Inc. (NYSE American: MAIA ) today announced its second broad provisional patent application covering the composition of matter for a new telomere-targeting molecule.

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that it will present data at the upcoming International Liver Congress of the European Association for the Study of the Liver taking place June 21-24, 2023 in Vienna, Austria.

Sagimet Biosciences Inc. today announced that it will present interim data from the FASCINATE-2 Phase 2b clinical trial of its lead product candidate, denifanstat, a fatty acid synthase (FASN) inhibitor, in nonalcoholic steatohepatitis (NASH) at the European Association for the Study of the Liver (EASL) Congress.

Seer, Inc., a leading life sciences company commercializing a disruptive new platform for proteomics, announced an expanded collaboration with Thermo Fisher Scientific, a world leader in serving science, to enable broader access to each company’s respective new technologies.

ChromaCode, a genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients and physicians, today announced a strategic investment from corporate venture capital fund Shimadzu Future Innovation Fund L.P., with general partner Global Brain Corporation.

Magenta Medical , developer of the world’s smallest heart pump, announced today the initiation of its FDA-approved Early Feasibility Study with the Elevate™ percutaneous Left Ventricular Assist Device.

SpectronRx, a leading radiopharmaceutical developer and manufacturer, and RLS, Inc. announced an agreement that will significantly enhance the supply and availability of diagnostic and therapeutic radiopharmaceuticals.

Capricor Therapeutics today announced an upcoming Type-B clinical meeting with the U.S. Food and Drug Administration (FDA), planned in early Q3 2023.

Justera Health Ltd. (CSE: VTAL) (OTCQB: SCRSF) (formerly ScreenPro Security Inc.) (“Justera” or the “Company”) is pleased to announce the launch of its intravenous (IV) therapy lounge in Vancouver, now open to the public.

A middle-brain region tied to the control of emotions likely prompts females to kill their young, a new study in mice shows.